Literature DB >> 16682691

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Laura Bonanni, Astrid Thomas, Marco Onofrj.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16682691     DOI： 10.1212/01.wnl.0000224698.67660.45

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  6 in total

1.  Validation of 18F-FDG-PET Single-Subject Optimized SPM Procedure with Different PET Scanners.

Authors:  Luca Presotto; Tommaso Ballarini; Silvia Paola Caminiti; Valentino Bettinardi; Luigi Gianolli; Daniela Perani
Journal:  Neuroinformatics       Date:  2017-04

2.  Amyloid pathology in the progression to mild cognitive impairment.

Authors:  Philip S Insel; Oskar Hansson; R Scott Mackin; Michael Weiner; Niklas Mattsson
Journal:  Neurobiol Aging       Date:  2017-12-27       Impact factor: 4.673

3.  Abnormal Serum Bilirubin/Albumin Concentrations in Dementia Patients With Aβ Deposition and the Benefit of Intravenous Albumin Infusion for Alzheimer's Disease Treatment.

Authors:  Xiaomei Zhong; Yuning Liao; Xinru Chen; Naikeng Mai; Cong Ouyang; Ben Chen; Min Zhang; Qi Peng; Wanyuan Liang; Weiru Zhang; Zhangying Wu; Xingxiao Huang; Caijun Li; Hong Chen; Weimin Lao; Chang-E Zhang; Xuejun Wang; Yuping Ning; Jinbao Liu
Journal:  Front Neurosci       Date:  2020-09-03       Impact factor: 4.677

Review 4.  Mild cognitive impairment: diagnosis, longitudinal course, and emerging treatments.

Authors:  Jennifer N Vega; Paul A Newhouse
Journal:  Curr Psychiatry Rep       Date:  2014-10       Impact factor: 5.285

5.  Clinical Experience with Cerebrospinal Fluid Aβ42, Total and Phosphorylated Tau in the Evaluation of 1,016 Individuals for Suspected Dementia.

Authors:  Leonardo Tariciotti; Matthew Casadei; Lawrence S Honig; Andrew F Teich; Guy M McKhann Ii; Giuseppe Tosto; Richard Mayeux
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  Cognitive Impairment in Chronic Obstructive Pulmonary Disease (COPD): Possible Utility of Marine Bioactive Compounds.

Authors:  Giulia Prinzi; Alessia Santoro; Palma Lamonaca; Vittorio Cardaci; Massimo Fini; Patrizia Russo
Journal:  Mar Drugs       Date:  2018-09-04       Impact factor: 5.118
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.